The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12625000914460
Ethics application status
Approved
Date submitted
27/05/2025
Date registered
22/08/2025
Date last updated
22/08/2025
Date data sharing statement initially provided
22/08/2025
Type of registration
Prospectively registered

Titles & IDs
Public title
Postoperative effect of chewing gum on paediatric stoma reversal: A Randomized Controlled Trial
Scientific title
Postoperative Impact of chewing gum on paediatric stoma reversal: A Randomized Controlled Trial
Secondary ID [1] 314524 0
nil
Universal Trial Number (UTN)
The Universal Trial Number (UTN) is U1111-1323-2760
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
pediatric stomas 337618 0
colostomy 337619 0
ileostomy 337620 0
post operative ileus 337621 0
Condition category
Condition code
Surgery 333953 333953 0 0
Other surgery
Oral and Gastrointestinal 333954 333954 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
In this study ,we will use hilal bubble gum which is a standard company manufacturing standard gums nationally. There will 2 arms.one arm will receive chewing gum 24 hours post operatively(intervention) every 3 hours, for 3 days. After every 3hours mother or care giver is advised to collect amount of un used gum, which will be recorded every 12 hours. Gum will be provided free of cost. while another arm will not receive it. Same age and disease groups will be selected for the study.
Intervention code [1] 331160 0
Treatment: Surgery
Comparator / control treatment
The group not receiving chewing is control group.
Control group
Active

Outcomes
Primary outcome [1] 341605 0
To determine duration of POST OPERATIVE ILEUS in both groups.
Timepoint [1] 341605 0
every 4 hours after intervention till return of bowel function in form of passage of flatus or stool.
Secondary outcome [1] 448055 0
length of hospital stay
Timepoint [1] 448055 0
This will be around the time of discharge from the hospital. These data will include • Morbidity • Postoperative recovery course • Length of hospital stay • time to full enteral feeds

Eligibility
Key inclusion criteria
children planned for stoma reversal, older than 7 years and less than 18 years.
Minimum age
7 Years
Maximum age
18 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
i. patients with documented allergies to the contents of chewing gum.
ii. Patients with a diagnosis of diabetes mellitus disease at the time of surgery.
iii. Patients who will be unconscious or unable to chew gum after 24 hours post-surgery.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
central randomization by computer.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
computerized sequence generation
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s

Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment outside Australia
Country [1] 27087 0
Pakistan
State/province [1] 27087 0
khyber pukhtoon khwa

Funding & Sponsors
Funding source category [1] 319076 0
Charities/Societies/Foundations
Name [1] 319076 0
Aftab welfare trust
Country [1] 319076 0
Pakistan
Primary sponsor type
Charities/Societies/Foundations
Name
Aftab welfare trust
Address
Country
Pakistan
Secondary sponsor category [1] 321536 0
Individual
Name [1] 321536 0
Muhammad Kabir, senior registrar,saidu group of teaching hospital swat.
Address [1] 321536 0
Country [1] 321536 0
Pakistan

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 317673 0
Ethical review board Saidu Medical Colledge
Ethics committee address [1] 317673 0
Ethics committee country [1] 317673 0
Pakistan
Date submitted for ethics approval [1] 317673 0
03/02/2025
Approval date [1] 317673 0
18/02/2025
Ethics approval number [1] 317673 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 141770 0
Dr Muhammad kabir
Address 141770 0
senior registarar,pediatric surgery unit,saidub group of teaching hospital swat,KPK,Pakistan.post code.19200
Country 141770 0
Pakistan
Phone 141770 0
+92 03425668673
Fax 141770 0
Email 141770 0
Contact person for public queries
Name 141771 0
muhammad kabir
Address 141771 0
senior registarar,pediatric surgery unit,saidub group of teaching hospital swat,KPK,Pakistan.post code.19200
Country 141771 0
Pakistan
Phone 141771 0
+923425668673
Fax 141771 0
Email 141771 0
Contact person for scientific queries
Name 141772 0
muhammad kabir
Address 141772 0
senior registarar,pediatric surgery unit,saidub group of teaching hospital swat,KPK,Pakistan.post code.19200
Country 141772 0
Pakistan
Phone 141772 0
+92 03425668673
Fax 141772 0
Email 141772 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
Anyone
Conditions for requesting access:
No requirements
What individual participant data might be shared?
De-identified individual participant data:
All outcomes data
Published results
What types of analyses could be done with individual participant data?
Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
A finite period of: 3 years
Where can requests to access individual participant data be made, or data be obtained directly?
Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.